Hippocrates (Kos, c.460-c.370 BC) reminds us that "It is more important to know what sort of person has a disease than to know what sort of disease a person has". This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.
How I faced my prostate cancer: a molecular biologist's perspective
Zucali, Paolo Andrea;Guazzoni, Giorgio;Colombo, Piergiuseppe;Scorsetti, Marta;Franzese, Ciro;Asselta, Rosanna;Soldà, Giulia;Duga, Stefano
2021-01-01
Abstract
Hippocrates (Kos, c.460-c.370 BC) reminds us that "It is more important to know what sort of person has a disease than to know what sort of disease a person has". This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
s41698-021-00229-5.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
618.02 kB
Formato
Adobe PDF
|
618.02 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
